Literature DB >> 16024934

A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.

Frank Jessen1, Frank Traeber, Nikolaus Freymann, Wolfgang Maier, Hans-H Schild, Reinhard Heun, Wolfgang Block.   

Abstract

OBJECTIVE: To investigate group differences and correlations and to determine the sensitivity and specificity of different measures of the neuronal marker N-acetylaspartate (NAA) in the medial temporal lobe of Alzheimer's Disease (AD) patients.
METHODS: The metabolic ratio NAA/creatine (Cr), the absolute concentration of NAA referenced against brain tissue (BT) water and NAA multiplied with the amount of BT in the proton magnetic resonance spectroscopy (1H-MRS) voxel were assessed in patients and healthy controls with a single-voxel 1H-MRS protocol.
RESULTS: All measures were significantly lower in AD patients compared with controls. NAA/Cr and NAA correlated weakly, and there was no correlation of NAA with the amount of BT in the voxel. The highest specificity (87%) at a sensitivity of 80% was observed for NAA multiplied with the amount of BT in the voxel. There was no correlation of the MMSE with any of the NAA parameters.
CONCLUSIONS: NAA/Cr does not reflect NAA concentration very well. NAA is not correlated with brain atrophy. The BT volume in the 1H-MRS voxel in combination with the concentration of NAA discriminates AD from healthy controls sufficiently. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024934     DOI: 10.1159/000087095

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  8 in total

1.  [Novel neuroimaging perspectives in the diagnosis of dementia].

Authors:  F Jessen
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

Review 2.  Various MRS application tools for Alzheimer disease and mild cognitive impairment.

Authors:  F Gao; P B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-17       Impact factor: 3.825

Review 3.  Magnetic resonance imaging of Alzheimer's disease.

Authors:  Stéphane Lehéricy; Malgorzata Marjanska; Lilia Mesrob; Marie Sarazin; Serge Kinkingnehun
Journal:  Eur Radiol       Date:  2006-07-25       Impact factor: 5.315

4.  Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Francesco Bellanti; Vidyasagar Naik Bukke; Archana Moola; Rosanna Villani; Caterina Scuderi; Luca Steardo; Gianmauro Palombelli; Rossella Canese; Sarah Beggiato; Mario Altamura; Gianluigi Vendemiale; Gaetano Serviddio; Tommaso Cassano
Journal:  Front Aging Neurosci       Date:  2022-05-24       Impact factor: 5.702

5.  Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.

Authors:  Shuang-Qing Chen; Pei-Jun Wang; Gao-Jun Ten; Wei Zhan; Ming-Hua Li; Feng-Chao Zang
Journal:  Dement Geriatr Cogn Disord       Date:  2010-01-06       Impact factor: 2.959

6.  Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

Authors:  Sanjay J Mathew; Rebecca B Price; Xiangling Mao; Eric L P Smith; Jeremy D Coplan; Dennis S Charney; Dikoma C Shungu
Journal:  Biol Psychiatry       Date:  2007-10-29       Impact factor: 13.382

7.  Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.

Authors:  Yan Lin; Jianli Yao; Yaowen Chen; Li Pang; Haihong Li; Zhen Cao; Kezeng You; Haiyang Dai; Renhua Wu
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

Review 8.  Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses.

Authors:  Martijn C de Wilde; Bruno Vellas; Elodie Girault; Aysun Cetinyurek Yavuz; John W Sijben
Journal:  Alzheimers Dement (N Y)       Date:  2017-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.